- Home
- ICLR vs REG Comparison
ICLR vs REG Comparison
Compare ICLR & REG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- REG
- Stock Information
- Founded
- ICLR 1990
- REG 1963
- Country
- ICLR Ireland
- REG United States
- Employees
- ICLR N/A
- REG N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- REG Real Estate Investment Trusts
- Sector
- ICLR Health Care
- REG Real Estate
- Exchange
- ICLR Nasdaq
- REG Nasdaq
- Market Cap
- ICLR 11.5B
- REG 12.9B
- IPO Year
- ICLR 1998
- REG 1993
- Fundamental
- Price
- ICLR $133.96
- REG $72.38
- Analyst Decision
- ICLR Buy
- REG Buy
- Analyst Count
- ICLR 12
- REG 12
- Target Price
- ICLR $206.64
- REG $78.08
- AVG Volume (30 Days)
- ICLR 2.1M
- REG 881.4K
- Earning Date
- ICLR 04-30-2025
- REG 04-29-2025
- Dividend Yield
- ICLR N/A
- REG 3.90%
- EPS Growth
- ICLR 11.53
- REG 2.69
- EPS
- ICLR 9.19
- REG 2.11
- Revenue
- ICLR $8,192,621,999.00
- REG $1,522,885,000.00
- Revenue This Year
- ICLR $1.63
- REG $1.31
- Revenue Next Year
- ICLR $4.82
- REG $4.33
- P/E Ratio
- ICLR $15.07
- REG $34.31
- Revenue Growth
- ICLR N/A
- REG 7.57
- 52 Week Low
- ICLR $133.28
- REG $58.19
- 52 Week High
- ICLR $347.72
- REG $78.18
- Technical
- Relative Strength Index (RSI)
- ICLR 33.96
- REG 53.65
- Support Level
- ICLR $135.00
- REG $71.28
- Resistance Level
- ICLR $141.96
- REG $72.75
- Average True Range (ATR)
- ICLR 6.69
- REG 1.41
- MACD
- ICLR 0.43
- REG 0.12
- Stochastic Oscillator
- ICLR 3.63
- REG 55.76
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About REG Regency Centers Corporation
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 482 properties, which includes nearly 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.